Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Down Syndrome Cell Adhesion Molecule (DSCAM) (Middle Region) Peptide

DSCAM Reactivité: Humain Hôte: Synthetic BP, WB, IP
N° du produit ABIN976007

Aperçu rapide pour Down Syndrome Cell Adhesion Molecule (DSCAM) (Middle Region) Peptide (ABIN976007)

Antigène

DSCAM (Down Syndrome Cell Adhesion Molecule (DSCAM))

Origine

Humain

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunoprecipitation (IP)
  • Protein Region

    Middle Region

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-DSCAM antibody (Catalog #: ARP45086_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    DSCAM (Down Syndrome Cell Adhesion Molecule (DSCAM))

    Sujet

    DSCAM is a cell adhesion molecule that can mediate cation-independent homophilic binding activity. DSCAM could be involved in nervous system development.

    Alias Symbols: CHD2-42, CHD2-52

    Protein Interaction Partner: ESR1,FOXA1,POLR2A,PAK1

    Protein Size: 2012

    Poids moléculaire

    220 kDa

    ID gène

    1826

    NCBI Accession

    NM_001389, NP_001380

    UniProt

    O60469
Vous êtes ici:
Chat with us!